Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-Beth Levy Researcher Activity Profile

Research Author Detailed Information 

profile photo of Beth LevyBeth levy researcher

Beth Levy Publication Rate By Year

Beth Levy has published 1 paper(s) in 1949, 1 paper(s) in 1992, 1 paper(s) in 2005, 5 paper(s) in 2006, 14 paper(s) in 2007, 9 paper(s) in 2008, for a total of 31 research publications in total.

Beth B Levy Author Information

LAST NAME: levy

FIRST NAME: Beth

INITIALS: b

AFFILIATION:

Papers

Beth Levy's Publication Record

  1. Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Year Published: 2005
  2. Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.
  3. Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors. Year Published: 2006
  4. Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, 1402 South Grand Boulevard, St. Louis, MO 63104, USA. slyws@slu.edu
  5. Increasing the power for detecting impairment in older adults with the Faces subtest from Wechsler Memory Scale-III: an empirical trial. Year Published: 2006
  6. Harvard Medical School, Department of Psychiatry, 115 Mill St., Belmont, MA, USA. boaz_levy@hms.harvard.edu
  7. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Year Published: 2006
  8. College of Nursing, University of Iowa, Iowa City, Iowa 52241, USA. mary-clark@uiowa.edu
  9. Central Nervous System-directed AAV2/5-Mediated Gene Therapy Synergizes with Bone Marrow Transplantation in the Murine Model of Globoid-cell Leukodystrophy. Year Published: 2006
  10. [1] 1Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA [2] 2Department of Pediatrics, Mackay Memorial Hospital, and Mackay Medicine Nursing and Management College, Taipei, Taipei, Taiwan.
  11. Clinical response to persistent, low-level beta-glucuronidase expression in the murine model of mucopolysaccharidosis type VII. Year Published: 2007
  12. Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
  13. High-mobility group box 1 protein plasma concentrations during septic shock. Year Published: 2007
  14. ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin) and endothelial dysfunction in sepsis: marker or culprit? Year Published: 2007
  15. Infectious keratitis: what have we learned? Year Published: 2007
  16. From Bausch & Lomb, Inc., Rochester, NY.
  17. Session v: discussion and summary. Year Published: 2007
  18. Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Year Published: 2007
  19. Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, University of Athens, Athens, Greece.
  20. Use of pressors in the management of septic shock. Year Published: 2007
  21. Use of pressors in the management of septic shock. Year Published: 2007
  22. Risk factors for contact lens related fusarium keratitis. Year Published: 2007
  23. Bausch & Lomb, 1400 Goodman St, Rochester, NY 14609. blevy@bausch.com.
  24. Infectious keratitis: what have we learned? Year Published: 2007
  25. Bausch & Lomb, Inc., Rochester, NY 14609, USA.
  26. Risk factors for contact lens related fusarium keratitis. Year Published: 2007
  27. Recognition for ego-involved materials. Year Published: 1949
  28. Risk factors for contact lens related fusarium keratitis. Year Published: 2007
  29. Infectious keratitis: what have we learned? Year Published: 2007
  30. Bausch & Lomb, Inc., Rochester, NY 14609, USA.
  31. Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Year Published: 2008
  32. Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Year Published: 2008
  33. Experience Gained by Basic Surgical Trainees in Varicose Vein Surgery over a 15 Year Period - Has it Changed? Year Published: 2008
  34. Senior House Officer, Brighton and Sussex University Hospitals NHS Trust, UK.
  35. Experience gained by basic surgical trainees in varicose vein surgery over a 15 year period - has it changed? Year Published: 2008
  36. Senior House Officer, Brighton and Sussex University Hospitals NHS Trust, UK.
  37. Desmoplastic infantile ganglioglioma: CT and MR features. Year Published: 1992
  38. Department of Radiology, St. Louis University Medical Center, MO 63110-0250.
  39. Experience gained by basic surgical trainees in varicose vein surgery over a 15 year period - has it changed? Year Published: 2008
  40. Senior House Officer, Brighton and Sussex University Hospitals NHS Trust, UK.
  41. High-mobility group box 1 protein plasma concentrations during septic shock. Year Published: 2007
  42. Hôpital Central, Service de Réanimation Médicale, 29 avenue du Maréchal de Lattre de Tassigny, 54000, Nancy, France. s.gibot@chu-nancy.fr
  43. Chemically modified {beta}-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII. Year Published: 2008
  44. Edward A. Doisy Department of Biochemistry and Molecular Biology and Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO 63104.
  45. Results of polyaxial locked-plate fixation of periarticular fractures of the knee. Surgical technique. Year Published: 2008
  46. Orthopedic Trauma Service, Florida Orthopedic Institute, 13020 Telecom Parkway, Temple Terrace, FL 33637, USA. docgjh@aol.com
  47. Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy. Year Published: 2006
  48. Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
  49. A teenage boy with late onset hemophagocytic lymphohistiocytosis with predominant neurologic disease and perforin deficiency. Year Published: 2008
  50. Department of Pediatrics, Saint Louis University, St. Louis, Missouri.
  51. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Year Published: 2008
  52. Department of Neurology, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, SW430B, 44 Binney St., Boston, MA 02115, USA. anorden@partners.org
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News